Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
urofollitropin
- Development stage
- Approved
- Lead developer
- Ferring Pharmaceuticals
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
Urofollitropin is a highly purified preparation of human follicle-stimulating hormone (FSH) extracted from the urine of postmenopausal women. It consists of two non-covalently linked glycoprotein subunits (alpha and beta) and is used to treat infertility in women by stimulating ovarian follicular growth and development in those with FSH deficiency or undergoing assisted reproductive technologies such as in vitro fertilization (IVF). Urofollitropin acts by mimicking endogenous FSH to promote the maturation of ovarian follicles. It is typically administered via subcutaneous or intramuscular injection and often used alongside human chorionic gonadotropin (hCG) to induce ovulation[1][2][3][4][5].
- Brand names
- BravelleFertinexMetrodin
- Other names
- follicle-stimulating hormone humanFSHhFSH
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on urofollitropin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on urofollitropin.